Sunday, June 02, 2002

Turning a side effect into success: Leonard Schliefer tried to develop a drug that would cure ALS (Lou Gehrig's disease), but it failed because patients kept losing too much weight as a side effect. Now, his company Regeneron thinks it could turn into the next big weight loss drug for obese baby boomers. Viagra redux!